Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1990; Volume 37,Issue 5
  • You have access
    Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
    F S Wu, T T Gibbs and D H Farb
    Molecular Pharmacology May 1990, 37 (5) 597-602;
  • You have access
    Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
    D C Javitt, M J Frusciante and S R Zukin
    Molecular Pharmacology May 1990, 37 (5) 603-607;
  • You have access
    Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
    S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
    Molecular Pharmacology May 1990, 37 (5) 608-613;
  • You have access
    Solubilization of active somatostatin receptors from rat brain.
    H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
    Molecular Pharmacology May 1990, 37 (5) 614-621;
  • You have access
    Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
    K J Ivins and P B Molinoff
    Molecular Pharmacology May 1990, 37 (5) 622-630;
  • You have access
    Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
    C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
    Molecular Pharmacology May 1990, 37 (5) 631-638;
  • You have access
    Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
    W E Evans and M V Relling
    Molecular Pharmacology May 1990, 37 (5) 639-642;
  • You have access
    Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
    A E Rettie, B D Bogucki, I Lim and G P Meier
    Molecular Pharmacology May 1990, 37 (5) 643-651;
  • You have access
    Differential expression of gamma-aminobutyric acidA receptor subunits.
    K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
    Molecular Pharmacology May 1990, 37 (5) 652-657;
  • You have access
    Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
    E De Clercq, R Bernaerts, A Merta and B Rosenwirth
    Molecular Pharmacology May 1990, 37 (5) 658-664;
  • You have access
    Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
    A Fridland, M C Connelly and R Ashmun
    Molecular Pharmacology May 1990, 37 (5) 665-670;
  • You have access
    Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    D H Maurice and R J Haslam
    Molecular Pharmacology May 1990, 37 (5) 671-681;
  • You have access
    Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
    E B Haddad, Y Landry and J P Gies
    Molecular Pharmacology May 1990, 37 (5) 682-688;
  • You have access
    Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
    F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
    Molecular Pharmacology May 1990, 37 (5) 689-693;
  • You have access
    Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    M Tiberi and J Magnan
    Molecular Pharmacology May 1990, 37 (5) 694-703;
  • You have access
    Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
    R Brodersen, N Jørgensen, H Vorum and N Krukow
    Molecular Pharmacology May 1990, 37 (5) 704-709;
  • You have access
    gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
    D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
    Molecular Pharmacology May 1990, 37 (5) 710-719;
  • You have access
    Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
    M M White and M Aylwin
    Molecular Pharmacology May 1990, 37 (5) 720-724;
  • You have access
    Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
    A K Ghose and G M Crippen
    Molecular Pharmacology May 1990, 37 (5) 725-734;
  • You have access
    Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
    A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
    Molecular Pharmacology May 1990, 37 (5) 735-741;
  • You have access
    Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
    D A Conner and T E Mansour
    Molecular Pharmacology May 1990, 37 (5) 742-751;
  • You have access
    Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
    J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
    Molecular Pharmacology May 1990, 37 (5) 752-757;
  • You have access
    Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
    S L Swope and A Schonbrunn
    Molecular Pharmacology May 1990, 37 (5) 758-766;
  • You have access
    Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
    P E Reilly, D A Thompson, S R Mason and W D Hooper
    Molecular Pharmacology May 1990, 37 (5) 767-774;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 37, Issue 5
1 May 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics